A Study of UCB and MSCs in Children With CP: ACCeNT-CP

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

April 10, 2018

Primary Completion Date

February 26, 2020

Study Completion Date

May 31, 2021

Conditions
Cerebral Palsy
Interventions
BIOLOGICAL

Infusion of allogeneic umbilical cord blood

Subjects will receive a single infusion of allogeneic umbilical cord blood at the baseline visit.

BIOLOGICAL

Infusion of MSCs

Subjects will receive 3 infusions of MSCs (baseline, 3 months and 6 months).

Trial Locations (1)

27705

Duke University Medical Center, Durham

All Listed Sponsors
collaborator

The Marcus Foundation

OTHER

lead

Joanne Kurtzberg, MD

OTHER

NCT03473301 - A Study of UCB and MSCs in Children With CP: ACCeNT-CP | Biotech Hunter | Biotech Hunter